Open AccessP1534: SAFETY AND TOLERABILITY OF NIPOCALIMAB ADMINISTERED AT DIFFERENT RATES OF INTRAVENOUS INFUSION IN HEALTHY ADULTS: A PHASE 1 PLACEBO‐CONTROLLED SINGLE‐DOSE STUDY
Author(s) -
Leu J.,
Vermeulen A.,
Ling L.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000848992.72150.d6
Subject(s) - tolerability , medicine , adverse effect , placebo , autoimmune hemolytic anemia , anemia , rituximab , randomized controlled trial , pharmacokinetics , anesthesia , gastroenterology , pathology , lymphoma , alternative medicine